Printer Friendly

DATASCOPE SUBMITS VASOSEAL PRE-MARKET APPROVAL APPLICATION

 DATASCOPE SUBMITS VASOSEAL PRE-MARKET APPROVAL APPLICATION
 MONTVALE, N.J., Feb. 3 /PRNewswire/ -- Datascope Corp. (NASDAQ: DSCP) announced that the Pre-Market Approval (PMA) application for its VasoSeal(TM) product was submitted to the U.S. Food and Drug Administration today.
 VasoSeal, announced by the company in April 1991, is the first device that can rapidly seal the arterial puncture created for coronary and peripheral angioplasty, angiography and other procedures requiring arterial catheterizations. The company estimates more than 4.5 million such procedures were performed throughout the world in 1991 including 3.2 million in the United States.
 -0- 2/3/92
 /CONTACT: Lawrence Saper, chairman of Datascope, 201-307-5508/
 (DSCP) CO: Datascope Corp. ST: New Jersey IN: HEA SU:


GK-OS -- NY038 -- 6092 02/03/92 10:50 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 3, 1992
Words:126
Previous Article:NATURAL MICROSYSTEMS UNVEILS 16-TRUNK, 8-STATION SYSTEM FOR CALL CENTERS
Next Article:THE FUTURE NOW, INC. ANNOUNCES 1991 RESULTS
Topics:


Related Articles
DATASCOPE REPORTS 42 PERCENT RISE IN SECOND QUARTER NET
DATASCOPE RESPONDS TO FDA REVIEW OF VASOSEAL PMA
DATASCOPE REPORTS THIRD QUARTER EARNINGS AND REGULATORY ACTIONS; CONFIRMS FDA PANEL REVIEW FOR VASOSEAL PMA
DATASCOPE RECEIVES APPROVABLE LETTER FOR VASOSEAL FROM FDA
DATASCOPE REPORTS HIGHER FIRST QUARTER EARNINGS AND U.S. SALES LAUNCH OF VASOSEAL
DATASCOPE LAUNCHES VASOSEAL AT AHA
Datascope Reports 1996 Year-End Results; Announces FDA Approval of Early Ambulation Labeling for VasoSeal
Datascope Expects Second Quarter Results Above Wall Street Expectations
Datascope Announces FDA Approval of VasoSeal(R) For Use Following Stent Implantation
Datascope Receives FDA Approval to Sell Second Generation VasoSeal(R) in the United States.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters